Brief: Genmab Says Orbis Investment Management Holds 4.99% Of Genmab Voting Rights As Of June 12
15/06/2026 17:05
BRIEF-Genmab Says Orbis Investment Management Holds 4.99% Of Genmab Voting Rights As Of June 12 June 15 (Reuters) - Genmab A/S GMAB.CO:
GENMAB - ORBIS INVESTMENT MANAGEMENT HOLDS 4.99% OF GENMAB VOTING RIGHTS AS OF JUNE 12, 2026
Source text: ID:nGNX4ZWq60
Further company coverage: GMAB.CO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genmab A/S
See all newsBrief: Genmab Says Orbis Investment Management Holds 4.99% Of Genmab Voting Rights As Of June 12
Brief: Genmab Announces Epcoritamab Monotherapy And Epcoritamab-Based Combination Regimens Demonstrate High Response Rates In Elderly Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Brief: Genmab Presents Epcore Fl-1 Data Showing Consistent Efficacy, Safety For Epcoritamab Combination
Brief: Genmab Says Orbis Investment Management Limited Holds 5.08% Of Genmab A/S As Of May 8, 2026
Genmab falls after 'uneventful' Q1, profit miss